Stoke Therapeutics, Inc.

STOK

$27.00

Name : Stoke Therapeutics, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $1,765,969,280.00

EPSttm : -3.81

Stoke Therapeutics, Inc.

$27.00

0.77%

$0.21

STOK — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

18.92

Margin Of Safety %

Put/Call OI Ratio

10.25

EPS Next Q Diff

-0.02

EPS Last/This Y

-3.91

EPS This/Next Y

0.26

Price

27.18

Target Price

46.38

Analyst Recom

Performance Q

-17.47

Upside

-281.6%

Beta

1.37

Ticker: STOK

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-10-12	STOK	24.13	0.25	0.43	1312
2026-10-13	STOK	22.54	0.25	999.99	1323
2026-10-14	STOK	23.28	0.25	5000.50	1324
2026-10-15	STOK	24.61	9.71	999.99	11324
2026-10-16	STOK	24.2	9.72	1.50	11327
2026-10-19	STOK	24.84	16.45	0.00	10837
2026-10-20	STOK	26.63	11.60	0.22	11105
2026-10-21	STOK	25.69	11.13	0.00	11148
2026-10-22	STOK	25.72	11.13	1.00	11148
2026-10-23	STOK	25.01	11.12	0.00	11150
2026-10-26	STOK	25.44	11.04	0.40	11157
2026-10-27	STOK	26.12	11.01	0.03	11161
2026-10-28	STOK	26.44	10.88	0.33	11177
2026-10-29	STOK	26.32	10.81	0.00	11185
2026-10-30	STOK	26.22	10.77	0.00	11189
2026-11-02	STOK	26.43	10.72	1.50	11193
2026-11-03	STOK	26.99	10.71	0.00	11202
2026-11-04	STOK	27.43	10.61	2.18	11211
2026-11-05	STOK	26.08	10.55	0.00	11217
2026-11-06	STOK	26.7	10.48	0.13	11224
2026-11-09	STOK	27.76	10.32	0.04	11240
2026-11-10	STOK	27.22	10.25	0.00	11248
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-10-12	STOK	24.16	-40.5	-	-3.62
2026-10-13	STOK	22.55	-40.5	-	-3.62
2026-10-14	STOK	23.28	-40.5	-	-3.62
2026-10-15	STOK	24.61	-40.5	-	-3.62
2026-10-16	STOK	24.20	-40.7	-	-3.62
2026-10-19	STOK	24.84	-40.7	-	-3.62
2026-10-20	STOK	24.84	-40.7	-	-3.62
2026-10-21	STOK	26.63	-40.7	-	-3.62
2026-10-22	STOK	25.71	-40.7	-	-3.62
2026-10-23	STOK	25.01	-40.7	-	-3.62
2026-10-26	STOK	25.44	-40.7	-	-3.62
2026-10-27	STOK	26.12	-40.7	-	-3.62
2026-10-28	STOK	26.44	-40.7	-	-3.62
2026-10-29	STOK	26.31	-40.7	-	-3.62
2026-10-30	STOK	26.22	-40.7	-	-3.62
2026-11-02	STOK	26.46	0.0	-	-3.62
2026-11-03	STOK	27.00	0.0	-	-4.12
2026-11-04	STOK	27.42	0.0	-	-4.03
2026-11-05	STOK	26.08	0.0	-	-4.03
2026-11-06	STOK	26.52	0.0	-	-4.03
2026-11-09	STOK	27.72	0.0	-	-4.03
2026-11-10	STOK	27.18	-23.4	-	-4.03
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

21 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-10-12	STOK	-0.43	9.91	21.51
2026-10-13	STOK	-0.43	9.91	21.51
2026-10-14	STOK	-0.43	9.91	21.51
2026-10-15	STOK	-0.43	9.91	21.51
2026-10-16	STOK	-0.43	9.91	21.51
2026-10-19	STOK	-0.43	9.93	21.51
2026-10-20	STOK	-0.43	9.93	21.51
2026-10-21	STOK	-0.43	9.93	21.51
2026-10-22	STOK	-0.43	9.93	21.51
2026-10-23	STOK	-0.43	9.93	21.51
2026-10-26	STOK	-0.43	9.45	21.51
2026-10-27	STOK	-0.43	9.45	19.18
2026-10-28	STOK	-0.43	9.45	19.18
2026-10-29	STOK	-0.43	9.45	19.18
2026-10-30	STOK	-0.43	9.45	19.18
2026-11-02	STOK	-0.43	9.51	19.18
2026-11-03	STOK	-0.43	9.51	19.18
2026-11-05	STOK	-0.49	9.51	19.09
2026-11-06	STOK	-0.47	9.51	19.09
2026-11-09	STOK	-0.47	9.64	18.92
2026-11-10	STOK	-0.47	9.64	18.92
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

21 items 1 of 1

Last Quarter Act. EPS

-1.08

Avg. EPS Est. Current Quarter

-0.97

Avg. EPS Est. Next Quarter

-1.1

Insider Transactions

-0.47

Institutional Transactions

9.64

Beta

1.37

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

32.4

Max Drawdown 5-Year %

-89

Target Price

46.38

P/E

Forward P/E

PEG

P/S

63.09

P/B

P/Free Cash Flow

EPS

-3.8

Average EPS Est. Cur. Y

-4.03

EPS Next Y. (Est.)

-3.77

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-862.07

Relative Volume

0.8

Return on Equity vs Sector %

-95.3

Return on Equity vs Industry %

-75.6

EPS 1 7Days Diff

-0.4

EPS 1 30Days Diff

-0.41

EBIT Estimation

◆ STOK Healthcare

$27.21

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

14/20

Pullback

10/25

Volume

7/15

Valuation

12/20

TP/AR

2/10

Options

3/10

RSI

55.3

Range 1M

79.2%

Sup Dist

1.6%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

6/25

Growth

6/30

Estimates

0/20

Inst/Vol

6/15

Options

4/10

EPS Yr

-3201.7%

EPS NY

-3.2%

52W%

28.5%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +70.5% upside

Quality

6/30

Valuation

12/30

Growth

1/25

Stability

9/10

LT Trend

2/5

Upside

+70.5%

Quality

STOK — P/E HistoricalBiotechnology

Stoke Therapeutics, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 170

Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression. The company utilizes its proprietary Targeted Augmentation of Nuclear Gene Output (TANGO) approach in developing antisense oligonucleotides (ASOs) to selectively restore protein levels. Its lead product candidates include STK-002, which is in Phase 1 clinical trials for the treatment of autosomal dominant optic atrophy; and Zorevunersen (STK-001), an investigational new medicine for the treatment of Dravet syndrome is being evaluated in phase 3 clinical trials. The company also develops programs focused on various targets, including haploinsufficiency diseases of the central nervous system and eye. It has a license and collaboration with Biogen Inc. for the development and commercialization of zorevunersen medicine for the treatment of Dravet syndrome; and Acadia Pharmaceuticals Inc. for the discovery, development, and commercialization of novel RNA-based medicines for the treatment of genetic neurodevelopmental diseases. The company was formerly known as ASOthera Pharmaceuticals, Inc. and changed its name to Stoke Therapeutics, Inc. in May 2016. Stoke Therapeutics, Inc. was incorporated in 2014 and is headquartered in Bedford, Massachusetts.

STOK

Latest News

—

Caricamento notizie per STOK…

stock quote shares STOK – Stoke Therapeutics Inc. Stock Price stock today

news today STOK – Stoke Therapeutics Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch STOK – Stoke Therapeutics Inc. yahoo finance google finance

stock history STOK – Stoke Therapeutics Inc. invest stock market

stock prices STOK premarket after hours

ticker STOK fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: STOK

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y